Pomegranate peels, often discarded as waste, harbor a compound that could reshape how we think about cancer treatment—and even energy efficiency in industrial processes. A new study by Saidakhon T. Islamova, PhD, Associate Professor of the Medical Chemistry Department at Andijan State Medical Institute in Uzbekistan, reveals how punicalagin, a polyphenol extracted from pomegranate peels, impacts human cancer cells in ways that could inspire both medical and industrial innovation.
Islamova’s team focused on A549 cells, a line of human lung cancer cells, exposing them to varying concentrations of punicalagin over 72 hours. The results were telling. At lower doses—around 10 micrograms per milliliter—cell viability remained relatively stable at 86%, meaning most cells survived. But as the concentration increased to 200 micrograms per milliliter, viability plummeted to just over 51%. “This isn’t just a minor slowdown,” Islamova noted. “At higher doses, punicalagin becomes cytotoxic. The cells aren’t just alive but struggling to proliferate.”
What makes these findings particularly intriguing is the dual role of punicalagin as both an antioxidant and antibacterial agent. The same compound that shows promise in targeting cancer cells could also find applications in water treatment systems, where microbial contamination remains a persistent challenge. Imagine industrial facilities using pomegranate peel extracts—not synthetic chemicals—to disinfect water before discharge or reuse. That shift could reduce reliance on energy-intensive chlorination or UV systems, cutting operational costs and environmental footprints.
The study didn’t stop at cell survival. Even at sub-lethal doses, punicalagin-treated cells showed reduced growth compared to untreated controls. That suggests the compound doesn’t just kill cancer cells outright but may disrupt their ability to divide and spread. For industries dealing with biofilm formation in pipes or cooling towers, this could translate into more effective, lower-energy maintenance strategies.
Published in the *Caspian Journal of Environmental Sciences* (known in Russian as *Каспийский журнал экологических наук*), the research adds to a growing body of evidence that natural compounds can outperform synthetic alternatives in specific applications. While punicalagin’s path to clinical use is still long, its potential in less-regulated sectors—like water purification or surface disinfection—could accelerate adoption.
Islamova’s work hints at a future where agricultural waste isn’t just repurposed but strategically leveraged. Pomegranate peels, once a nuisance, might become a resource for industries seeking to balance efficacy with sustainability. The question now isn’t whether punicalagin can make a difference, but how soon we can scale its applications beyond the lab.